Kenfarb & Co. Novo Nordisk A S Transaction History
Kenfarb & Co.
- $108 Million
- Q3 2023
A detailed history of Kenfarb & Co. transactions in Novo Nordisk A S stock. As of the latest transaction made, Kenfarb & Co. holds 2,500 shares of NVO stock, worth $356,850. This represents 0.21% of its overall portfolio holdings.
Number of Shares
2,500
Previous 1,250
100.0%
Holding current value
$356,850
Previous $202,000
12.38%
% of portfolio
0.21%
Previous 0.18%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,865Shares Held
309MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$3.01 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.96 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.86 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.71 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.69 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $322B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...